Skip to main content

Bedfordshire

First response from the diabetes lead

​Dear Nick

Thank you for your email;  I have forwarded to the CCG Medicines lead for a reply.  We already have limited access to the Libre along RMOC lines and anticipate adopting the new guidance in full.

Yours

Final Response - Links have been changed - this works though: LINK


Comprehensive reply from Bedfordshire CCG (original letter) :


Dear Mr Cahm

FreeStyle Libre® Glucose Monitor

Thank you for your letter regarding the availability of the Freestyle Libre® Glucose Monitor on the NHS in Bedfordshire.

In June 2018, the Bedfordshire and Luton Joint Prescribing Committee (JPC) agreed to support the prescribing of Freestyle Libre® in adults and children in line with the recommendations produced by the East of England Prioritise Advisory Committee (EoEPAC). In addition Bedfordshire CCG agreed to fund Freestyle Libre® subject to minor amendments in line with the JPC recommendations and criteria outlined in the bulletins below:

·         Bulletin 266: FreeStyle Libre ® (Flash Glucose Scanning {FGS}):- Locally agreed JPC recommendations and East of England Priorities Advisory Committee (EoEPAC) guidance for the use of FGS in adults with type 1 diabetes
Link no longer works...see above

·         Bulletin 265: FreeStyle Libre ® (Flash Glucose Scanning {FGS}):- Locally agreed JPC recommendations and East of England Priorities Advisory Committee (EoEPAC) guidance for the use of FGS in children and young people with type 1 diabetes age 4 up to {i.e less than} age 19.
Link no longer works...see above

As per the bulletins above it was agreed that the supply of the devices/sensors would be through the Specialist Diabetes Teams at Bedford Hospital and the Luton and Dunstable Hospital with no GP prescribing. Consequently prescriptions for FreeStyle Libre ® would not appear on BCCG primary care prescribing data.

BCCG are implementing the National Criteria set out by NHS England with effect from the 1st April 2019 and at this point transfer the prescribing of FreeStyle Libre ® sensors to GPs within primary care.  Currently BCCG does not operate a traffic light system for the availability of medications, however the initiation of FreeStyle Libre ® in line with the National Criteria will be through the Diabetes Specialist Teams. As you may be aware the guidance published on the 8th March and we are currently working with the diabetes teams to implement, the paperwork will be available in due course, on public facing website.



I hope that we have been able to answer your questions relating to the availability of the FreeStyle Libre® in Bedfordshire.  Please get in touch if I can be of further help.

Yours sincerely



Complaints, Enquiries and FOI Team
Bedfordshire Clinical Commissioning Group

Comments

Popular posts from this blog

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) .  The major piece of work with respect to this is finding the right person to contact.  However, I have s

July Update - CCGs Under Pressure!

The heat is unbearable in some parts, not only in the environment, but also hopefully the heat directed at the decision-makers in 'non-compliant' CCGs who are either refusing to accept that Libre is a revolutionary tool for many T1s or have agreed to fund, but then set crippling criteria. Latest Prescribing Data Progress in prescribing continues, with stabilisation in Scotland and a continuation of the steady rise in the other three countries of the UK.  The Wales May data should be out this week. As mentioned last month, the situation in Scotland is particularly promising and the excellent Edinburgh Centre for Endocrinology and the Scottish Health Technologies Group have published documents that should significantly help the Libre case.  These documents are based on the first six months of prescribing Libre. Healthcare Improvement Scotland Statement Flash Glucose Monitoring is associated with improved glycaemic control and quality of life in people with type 1 d